EX-21.1 3 ex21-1.htm

 

Exhibit 21.1

 

LIST OF SUBSIDIARIES

 

Subsidiary    Ownership    Country
NeuroAirmid Therapeutics, Inc.    50%    USA
ReCyte Therapeutics, Inc.    94.8%    USA
Reverse Bioengineering, Inc.    100%    USA